ENTA - Enanta Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.36B
Enterprise Value 32.16B
Trailing P/E 46.86
Forward P/E 132.98
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)14.23
Price/Book (mrq)7.07
Enterprise Value/Revenue 313.04
Enterprise Value/EBITDA 628.90

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2017
Most Recent Quarter (mrq)Mar 31, 2018

Profitability

Profit Margin 31.60%
Operating Margin (ttm)43.72%

Management Effectiveness

Return on Assets (ttm)14.28%
Return on Equity (ttm)17.42%

Income Statement

Revenue (ttm)165.6M
Revenue Per Share (ttm)8.66
Quarterly Revenue Growth (yoy)391.70%
Gross Profit (ttm)102.81M
EBITDA 74.72M
Net Income Avi to Common (ttm)52.33M
Diluted EPS (ttm)2.61
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)256.72M
Total Cash Per Share (mrq)13.32
Total Debt (mrq)1.86M
Total Debt/Equity (mrq)0.56
Current Ratio (mrq)17.86
Book Value Per Share (mrq)17.31

Cash Flow Statement

Operating Cash Flow (ttm)49.34M
Levered Free Cash Flow (ttm)33.44M

Trading Information

Stock Price History

Beta 1.54
52-Week Change 3225.91%
S&P500 52-Week Change 313.55%
52 Week High 3127.77
52 Week Low 337.10
50-Day Moving Average 3116.98
200-Day Moving Average 392.33

Share Statistics

Avg Vol (3 month) 3243.06k
Avg Vol (10 day) 3251.84k
Shares Outstanding 519.27M
Float 13.62M
% Held by Insiders 124.59%
% Held by Institutions 178.15%
Shares Short (Jun 15, 2018) 41.07M
Short Ratio (Jun 15, 2018) 44.8
Short % of Float (Jun 15, 2018) 46.79%
Short % of Shares Outstanding (Jun 15, 2018) 45.58%
Shares Short (prior month May 15, 2018) 41.03M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A